Atrys Health debuts at the MAB with a rise of 8.1%
July 25, 2016
Santiago de Torres has indicated that "the capital increase and the stock market listing are part of a medium- and long-term growth strategy. These operations allow us to grow as a company, bringing our cancer diagnosis and treatment services to a greater number of patients, and accelerating the development of new diagnostic services as a result of our research and development projects. "
Picture: Santiago de Torres (President) and Isabel Lozano (CEO), at the moment of the bell ring.